If You Invested in Merrimack Pharmaceuticals, Inc. (MACK)
See the MACK overviewWhat $1,000 or $10,000 in MACK Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since Nov 16, 2015 |
|---|---|---|---|---|
| $1,000 | $1,213 +21% | $3,087 +209% | — | $224 -78% |
| $10,000 | $12,133 +21% | $30,867 +209% | — | $2,241 -78% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2024-05-24. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for MACK$1,000 Investment Over Time
MACK vs S&P 500Year-by-Year Returns
MACK annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2015Nov 16 to Dec 31 | $67.51 | $62.16 | -7.9% | -7.9% |
| 2016 | $62.16 | $32.10 | -48.4% | -52.4% |
| 2017 | $32.10 | $8.06 | -74.9% | -88.1% |
| 2018 | $8.06 | $3.04 | -62.3% | -95.5% |
| 2019 | $3.04 | $3.15 | +3.7% | -95.3% |
| 2020 | $3.15 | $6.89 | +118.7% | -89.8% |
| 2021 | $6.89 | $3.91 | -43.3% | -94.2% |
| 2022 | $3.91 | $11.46 | +193.1% | -83.0% |
| 2023 | $11.46 | $13.41 | +17.0% | -80.1% |
| 2024Dec 29, 2023 to May 24 | $13.41 | $15.13 | +12.8% | -77.6% |
About Merrimack Pharmaceuticals, Inc.
NASDAQ
Frequently Asked Questions
Merrimack Pharmaceuticals, Inc. investment returns
How much was $1,000 invested in Merrimack Pharmaceuticals, Inc. worth at its last close?
If you invested $1,000 in Merrimack Pharmaceuticals, Inc. (MACK) 5 years before its last close, on 2019-05-24, your investment was worth $3,087 on 2024-05-24, a +208.7% price return without dividends, growing at a compounded rate of 25.3% per year (CAGR).
Has Merrimack Pharmaceuticals, Inc. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare MACK performance over available time periods.
What is Merrimack Pharmaceuticals, Inc.'s average annual return?
The compound annual growth rate (CAGR) of MACK’s share price over the 5 years to May 24, 2024 is 25.3%, without dividends. Individual years vary a great deal, and MACK’s best recent full year was 2022 (+193.1%) while the worst was 2017 (-74.9%).
For informational and educational purposes only, not investment advice.
